fda warning bpc-157 not approved safety concerns peptides bpc 157 This is the first vote from the bpc-157 fda warning 2025 october – fda warning letters bpc-157 peptide

American Journal of Biomedical Science & Research , 15 (2), 153

However, prior to initiating combination therapy, a qualified provider should confirm that semaglutide monotherapy has been optimized and that metabolic biomarkers support the addition of lipotropic supplementation rather than dose adjustment, lifestyle modification, or alternative GLP-1 agents

Supports Brain and Nervous System Function: Helps maintain healthy brain function, cognitive performance, and normal nervous system activity by replenishing essential vitamins

The peptide also enhances growth factor activity, which helps tissue repair themselves faster than they would naturally

Not sure if its just propaganda, but about bp157 google search says, BPC-157 affects the heart primarily by interacting with the nitric oxide (NO) system and blood vessel pathways, showing potential cardioprotective, blood pressure-modulating, and anti-arrhythmic effects in early research. Thats the kind of stuff that seriously plagues a lot of people, including endurance athletes